Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

516
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
516
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

397
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
397

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data Volume and the Need for Clinical Decision Support in Glaucoma Care.

Ophthalmology science·2026
Same author

Extraction of Glaucoma Diagnosis, Type, and Severity from Clinical Notes using Secure Cloud-based Large Language Models.

medRxiv : the preprint server for health sciences·2026
Same author

GLLaucoMed: A Secure LLM-Powered Agentic Workflow for Automated Medication Extraction from Free-Text Glaucoma Clinical Notes.

medRxiv : the preprint server for health sciences·2026
Same author

Optic Disc Fundus Images Retain Biometric Identity Signals Under Deep Learning.

Research square·2026
Same author

Development and Pilot Testing of a Mobile App Psychosocial Intervention for Psychological Distress in Individuals with Glaucoma.

medRxiv : the preprint server for health sciences·2026
Same author

Reply to Comment on "RNFL Thickness in a Population-Based Cohort: The Canadian Longitudinal Study on Aging M2M (Machine-to-Machine) Study".

American journal of ophthalmology·2026
Same journal

Patient-specific implants for orbital fracture surgery.

Taiwan journal of ophthalmology·2026
Same journal

Evaluating large language models for glaucoma counseling: A pilot study of ChatGPT and Google Gemini responses in Traditional Chinese.

Taiwan journal of ophthalmology·2026
Same journal

Bony realignment after surgical removal of orbital implantation cysts: A case series.

Taiwan journal of ophthalmology·2026
Same journal

Lymphoepithelial carcinoma in the orbit: A case report and review of the treatment modalities.

Taiwan journal of ophthalmology·2026
Same journal

Persistent pupillary membrane and accessory iris membrane in cataract surgery.

Taiwan journal of ophthalmology·2026
Same journal

The new horizon of ophthalmic plastic and reconstructive surgery - From digital intelligence to precision intervention.

Taiwan journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2025

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software
08:57

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software

Published on: September 4, 2021

4.0K

Big data for imaging assessment in glaucoma.

Douglas R da Costa1, Felipe A Medeiros1

  • 1Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.

Taiwan Journal of Ophthalmology
|October 21, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) and deep learning (DL) offer new ways to detect and monitor glaucoma, a leading cause of blindness. These technologies aim to improve early diagnosis and track disease progression, helping to prevent vision loss.

Keywords:
Artificial intelligenceartificial intelligence modelbig datadata lakedeep learninggenerative artificial intelligenceglaucomamachine learning

More Related Videos

Doppler Optical Coherence Tomography of Retinal Circulation
10:46

Doppler Optical Coherence Tomography of Retinal Circulation

Published on: September 18, 2012

18.7K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K

Related Experiment Videos

Last Updated: Jun 10, 2025

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software
08:57

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software

Published on: September 4, 2021

4.0K
Doppler Optical Coherence Tomography of Retinal Circulation
10:46

Doppler Optical Coherence Tomography of Retinal Circulation

Published on: September 18, 2012

18.7K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K

Area of Science:

  • Ophthalmology and Computational Science
  • Artificial Intelligence in Healthcare

Background:

  • Glaucoma is a primary cause of irreversible blindness globally, affecting millions and often detected late.
  • Projections indicate over 110 million individuals will have glaucoma by 2040, underscoring the need for early detection.
  • Current treatments exist, but effective management hinges on timely diagnosis and continuous monitoring.

Purpose of the Study:

  • To review the application of Big Data and Artificial Intelligence (AI) in glaucoma research.
  • To explore AI and deep learning (DL) models for glaucoma screening, diagnosis, and progression monitoring.
  • To discuss innovative AI applications, including generative AI, in understanding glaucoma.

Main Methods:

  • Comprehensive literature review of Big Data and AI applications in glaucoma.
  • Analysis of various AI/DL models for screening, diagnosis, and monitoring disease progression.
  • Evaluation of AI's role in correlating structural and functional changes and assessing image quality.

Main Results:

  • AI and DL algorithms show significant potential for enhancing glaucoma screening and diagnosis.
  • These technologies can aid in monitoring disease progression and forecasting future changes.
  • Big Data analytics combined with AI offer deeper insights into glaucoma's underlying mechanisms.

Conclusions:

  • AI and Big Data are transformative tools in ophthalmology, particularly for glaucoma management.
  • These technologies promise to improve clinical practice, public health outcomes, and patient care.
  • Further research into innovative AI, like generative AI, is crucial for advancing glaucoma research.